Maravai LifeSciences (MRVI) Earnings Date, Estimates & Call Transcripts

$10.46
+0.60 (+6.09%)
(As of 05/10/2024 08:55 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 5Estimated
Actual EPS
(Feb. 22)
-$0.05 Missed By -$0.01
Consensus EPS
(Feb. 22)
-$0.04
Skip Charts & View Estimated and Actual Earnings Data

MRVI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRVI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Maravai LifeSciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.15) EPS
Next Year EPS Consensus Estimate: ($0.11) EPS

MRVI Earnings Date and Information

Maravai LifeSciences last posted its earnings data on February 22nd, 2024. The reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01. The business had revenue of $74.14 million for the quarter, compared to the consensus estimate of $62.99 million. Maravai LifeSciences has generated ($0.99) earnings per share over the last year (($0.99) diluted earnings per share). Earnings for Maravai LifeSciences are expected to grow in the coming year, from ($0.15) to ($0.11) per share. Maravai LifeSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.

Maravai LifeSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/5/2024
Estimated)
------- 
2/22/2024Q4 2023($0.04)($0.05)($0.01)$0.70$62.99 million$74.14 million
11/7/2023Q3 2023($0.03)($0.02)+$0.01$0.01$75.23 million$66.87 million
8/7/2023Q2 2023($0.02)($0.06)($0.04)($0.07)$70.30 million$68.91 million
5/8/2023Q1 2023$0.04$0.03($0.01)$0.06$79.72 million$79.03 million    
2/22/2023Q4 2022$0.34$0.35+$0.01$0.42$204.95 million$204.70 million    
11/2/2022Q3 2022$0.32$0.37+$0.05$0.40$193.83 million$191.26 million
8/4/2022Q2 2022$0.45$0.54+$0.09$0.55$234.91 million$242.73 million
5/5/2022Q1 2022$0.43$0.54+$0.11$0.58$232.29 million$244.30 million    
2/23/2022Q4 2021$0.38$0.45+$0.07$0.48$208.09 million$228.44 million    
11/10/2021Q3 2021$0.35$0.44+$0.09$0.65$199.68 million$204.81 million    
8/10/2021Q2 2021$0.32$0.44+$0.12$0.44$195.49 million$217.80 million    

Maravai LifeSciences Earnings - Frequently Asked Questions

When is Maravai LifeSciences's earnings date?

Maravai LifeSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on MRVI's earnings history.

Did Maravai LifeSciences beat their earnings estimates last quarter?

In the previous quarter, Maravai LifeSciences (NASDAQ:MRVI) missed the analysts' consensus estimate of ($0.04) by $0.01 with a reported earnings per share (EPS) of ($0.05). Learn more on analysts' earnings estimate vs. MRVI's actual earnings.

How much revenue does Maravai LifeSciences generate each year?

Maravai LifeSciences (NASDAQ:MRVI) has a recorded annual revenue of $288.95 million.

How much profit does Maravai LifeSciences generate each year?

Maravai LifeSciences (NASDAQ:MRVI) has a recorded net income of -$119.03 million. MRVI has generated -$0.99 earnings per share over the last four quarters.

What is Maravai LifeSciences's EPS forecast for next year?

Maravai LifeSciences's earnings are expected to grow from ($0.15) per share to ($0.11) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MRVI) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners